Drilldown: Medicines

Codeine (2)

Other values:

Search

None (32) · (multiple, generic dominant) (1) · Alfenta (1) · Darvon (1) · Demerol (1) · Dilaudid (1) · Dolophine (1) · Duragesic (1) · Heroin (1) · Krokodil (1) · Nubain (1) · Nucynta (1) · O-DSMT (1) · Opana (1) · Qulipta (1) · Stablon (1) · Stadol (1) · Suboxone (1) · Sufenta (1) · Talwin (1) · Ubrelvy (1) · Ultiva (1) · Vicodin (1) · Zavzpret (zavegepant) (1)

Research material · Classic Psychedelic · Stimulant · Opioid · Sedative-Hypnotic · Phenethylamine · Tryptamine · Benzodiazepine · Botanical · [[:Category:Antihypertensives|Antihypertensive]] · Dissociative · Anticonvulsant · Antidepressant · Plant Medicine · Analgesic · Antipsychotic · Antiparkinsonian · Empathogen · Neuroleptic · Cathinone

Other values:

Search

Potent mu-opioid receptor agonist (6) · Mu-opioid receptor agonist (4) · CGRP receptor antagonist (2) · Contains LSA (2) · Contains mescaline (2)

Other values:

Search

None (53) · Acute treatment of migraine with or without aura in adults (1) · Mild to moderate pain; cough suppression (low-dose). (1)

None (53) · 10 mg (one spray) intranasally in one nostril (1) · Adult: 15–60 mg every 4 hours as needed. (1)

None (53) · 10 mg/spray nasal solution (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

None (53) · 10 mg per 24 h (1) · 360 mg/day (1)

None (53) · Intranasal (1) · PO (only formulation marketed in the US). (1)

None (53) · 30–60 min (PO) (1) · Pain relief reported within 15 min in trials (1)

None (53) · 4–6 hours (1) · ~48 h sustained pain freedom in responders (1)

None (53) · 2.5–3 hours (1) · ~6.6 h (1)

None (53) · ~5% intranasal (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)

None (53) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) · Limited data; avoid (1)

None (53) · Rx (1) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)